A conspiracy of glioma and endothelial cells to invade the normal brain.
A conspiracy of glioma and endothelial cells to invade the normal brain. |
https://doi.org/10.18632/oncotarget.219
Abdessamad Zerrouqi,
and Erwin G Van Meir
|
1-4 |
Targeting Transcription Through Inhibition of TBP
Targeting Transcription Through Inhibition of TBP |
https://doi.org/10.18632/oncotarget.226
Thaddeus T. Schug
|
5-7 |
The Emerging Role of the Thrombin Receptor (PAR-1) in Melanoma Metastasis - a Possible Therapeutic Target
The Emerging Role of the Thrombin Receptor (PAR-1) in Melanoma Metastasis - a Possible Therapeutic Target |
https://doi.org/10.18632/oncotarget.211
Gabriel J. Villares,
Maya Zigler,
and Menashe Bar-Eli
|
8-17 |
Identification of Kinase Inhibitors that Target Transcription Initiation by RNA Polymerase II
Identification of Kinase Inhibitors that Target Transcription Initiation by RNA Polymerase II |
https://doi.org/10.18632/oncotarget.212
José M. Morachis,
Ruo Huang,
and Beverly M. Emerson
|
18-28 |
miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma
miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma |
https://doi.org/10.18632/oncotarget.213
Nijiro Nohata,
Yaeko Sone,
Toyoyuki Hanazawa,
Miki Fuse,
Naoko Kikkawa,
Hirofumi Yoshino,
Takeshi Chiyomaru,
Kazumori Kawakami,
Hideki Enokida,
Masayuki Nakagawa,
Makio Shozu,
Yoshitaka Okamoto,
and Naohiko Seki
|
29-42 |
Hsp90 can Accommodate the Simultaneous Binding of the FKBP52 and HOP Proteins
Hsp90 can Accommodate the Simultaneous Binding of the FKBP52 and HOP Proteins |
https://doi.org/10.18632/oncotarget.225
Zacariah L. Hildenbrand,
Sudheer K. Molugu,
Nadia Herrera,
Citlally Ramirez,
Chuan Xiao,
and Ricardo A. Bernal
|
43-58 |
A Robust Approach to Enhance Tumor-selective Accumulation of Nanoparticles
A Robust Approach to Enhance Tumor-selective Accumulation of Nanoparticles |
https://doi.org/10.18632/oncotarget.227
Yuan Qiao,
Xin Huang,
Sridhar Nimmagadda,
Renyuan Bai,
Verena Staedtke,
Catherine A. Foss,
Ian Cheong,
Matthias Holdhoff,
Yoshinori Kato,
Martin G. Pomper,
Gregory J. Riggins,
Kenneth W. Kinzler,
Luis A. Diaz,
Bert Vogelstein,
and Shibin Zhou
|
59-68 |
FAM190A Rearrangements Provide a Multitude of Individualized Tumor Signatures and Neo-antigens in Cancer
FAM190A Rearrangements Provide a Multitude of Individualized Tumor Signatures and Neo-antigens in Cancer |
https://doi.org/10.18632/oncotarget.220
Francesca Scrimieri,
Eric S. Calhoun,
Kalpesh Patel,
Rigu Gupta,
David L. Huso,
Ralph H. Hruban,
and Scott E. Kern
|
69-75 |
Targeting Translation Dependence in Cancer
Targeting Translation Dependence in Cancer |
https://doi.org/10.18632/oncotarget.218
Abba Malina,
Regina Cencic,
and Jerry Pelletier
|
76-88 |
Insights into 4E-BP1 and p53 mediated regulation of accelerated cell senescence
Insights into 4E-BP1 and p53 mediated regulation of accelerated cell senescence |
https://doi.org/10.18632/oncotarget.221
Suzan K. Chao,
Susan Band Horwitz,
and Hayley M. McDaid
|
89-98 |
Eradicating cancer cells: struggle with a chameleon
Eradicating cancer cells: struggle with a chameleon |
https://doi.org/10.18632/oncotarget.222
Jiabo Di,
Tjitske Duiveman-de Boer,
Carl G. Figdor,
and Ruurd Torensma
|
99-101 |